blog
Tested so far on mice, Dr. Eitan Okun’s vaccine targets amyloid beta protein, which clusters in the brains of people affected by the deadly disease. By Abigail Klein Leichman Alzheimer’s
Geisinger Health System has teamed with the National Kidney Foundation and an Israeli startup Healthy.io to launch a clinical trial to study the efficacy of smartphone-enabled urinalysis kits